Impact of Lower Respiratory Tract Infections on Health Status

ABSTRACT

Acute exacerbations of COPD have a broad range of effects on the patients in addition to cough and sputum production. These include malaise, increased dyspnea, diminished tolerance and social restriction. No single clinical or physiological measure captures this multiplicity of effects adequately. Health status measurement using instruments erroneously termed `quality of life' questionnaires can provide this integrative function. Validation studies have shown that these scores reflect exercise capacity, respiratory symptoms, disability in daily life, and impaired mood. Furthermore they relate to levels of arterial hypoxaemia in COPD and blood leucocyte count in patients with bronchiectasis. Health status scores have been shown to predict hospital readmission or death in patients with COPD. Recent studies have shown that whilst sputum color and volume recover within a week of starting treatment, full recovery of health status may take over three months. This is consistent with the observation that exacerbation frequency is strongly related to health status and a recent report that the rate of decline in health status over time is related to the frequency of exacerbations. Health status instruments were developed originally to measure treatment efficacy, but they also provide insights into acute exacerbations of COPD and their clinical importance.

KEYWORD

COPD - health status measurement - exacerbations - St. George's Respiratory Questionnaire (SGRQ) - quality of life

REFERENCES

• 1 Ware J E, Sherbourne C A, Davies A R. The MOS short-form general health survey.  Santa Monica, CA: Rand Corporation 1988
• 2 Kaplan R M, Atkins C J, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease.  J Chronic Dis . 1984;  37 85-95
• 3 Guyatt G H, Berman L B, Townsend M, Pugsley S O, Chambers L W. A measure of quality of life for clinical trials in chronic lung disease.  Thorax . 1987;  42 773-778
• 4 Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure for chronic airflow limitation-the St George's Respiratory Questionnaire.  Am Rev Respir Dis . 1992;  145 1321-1327
• 5 Okubadejo A A, Jones P W, Wedzicha J A. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.  Thorax . 1996;  51 44-47
• 6 Wilson C B, Jones P W, O'Leary C J, Cole P J, Wilson R. Validation of the St.  George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med . 1997;  156 536-541
• 7 Wilson C B, Jones P W, O'Leary C J, Hansell D M, Cole P J, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.  Eur Respir J . 1997;  10 1754-1760
• 8 Seemungal T AR, Donaldson G C, Paul E A, Bestall J C, Jefferies D J, Wedzicha J A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med . 1998;  157 1418-1422
• 9 Anie K, Lowton K, Jones P W. Changes in health status following an acute infective exacerbation of COPD.  Eur Respir J . 1997;  10(suppl 25) 148s
• 10 Seemungal T, Donaldson G C, Bhowmik A, Wedzicha J A. COPD patients may not recover to baseline lung function after exacerbation.  Eur Respir J . 1999;  14(suppl 30) 115s
• 11 Spencer S, Anie K, Jones P W. Annual rate of health status decline in COPD patients is significantly related to frequency of acute exacerbations.  Eur Respir J . 1999;  14(suppl 30) 19s